TLR4 and neoplasm: HMGB1, released from dying cancer cells, binds with TLR4 expressed on DCs to strengthen the antigen-presenting activity of DCs through activating the PI3K/AKT/mTOR signaling pathway, and promotes anti-tumor immune response of T cells (50, 51).